Acutaas Chemicals reported revenue of Rs. 433 crore in Q4FY26, marking a strong 40.3% YoY growth compared to Rs. 308 crore in Q4FY25. On a sequential basis, revenue grew by 10.1% from Rs. 393 crore, indicating continued momentum.

EBITDA stood at Rs. 183 crore, reflecting a sharp 116% YoY growth from Rs. 85 crore, while also increasing 21.8% QoQ. EBITDA margin improved significantly to 42.4% compared to 27.5% YoY and 38.3% in Q3FY26.

Net profit stood at Rs. 134 crore, registering a growth of 114% YoY and 26.4% sequentially, indicating strong profitability and operational leverage.

Commenting on results, Mr. Naresh Patel, Executive Chairman & Managing Director, Acutaas Chemicals Limited, said: “I am pleased to report a strong close to FY26, with Q4 revenue from operations reaching Rs. 4,328 million — up 40.3% year-on-year — and our highest ever PAT margin of 31.0%.

Our strategy is clear: build a diversified chemicals business across three high-growth verticals — Battery Chemicals, Semiconductors, and Pharmaceutical CDMO. By scaling these in parallel, we are de-risking our revenue base while creating multiple independent engines of compounding, long-term growth.

We enter FY27 from a position of strength. I am confident of delivering 25% revenue growth in FY27.”